# Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis

> **NCT04798755** · PHASE3 · UNKNOWN · sponsor: **Hospital San Carlos, Madrid** · enrollment: 192 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Adalimumab
- **DRUG:** Adalimumab+Methotrexate

## Key facts

- **NCT ID:** NCT04798755
- **Lead sponsor:** Hospital San Carlos, Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-12
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04798755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04798755, "Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04798755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*